 Jennifer Matsuda
Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Killer Cells, Natural | 16 | 2018 | 469 | 1.840 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 14 | 2024 | 335 | 1.180 |
Why?
| | Antigens, CD1 | 9 | 2008 | 58 | 0.980 |
Why?
| | Natural Killer T-Cells | 7 | 2016 | 67 | 0.970 |
Why?
| | T-Lymphocyte Subsets | 6 | 2022 | 415 | 0.840 |
Why?
| | Antigens, CD1d | 15 | 2018 | 68 | 0.810 |
Why?
| | Cell Differentiation | 9 | 2018 | 2003 | 0.620 |
Why?
| | Galactosylceramides | 7 | 2010 | 25 | 0.540 |
Why?
| | Transcription Activator-Like Effector Nucleases | 1 | 2016 | 6 | 0.500 |
Why?
| | Cell Movement | 5 | 2020 | 990 | 0.490 |
Why?
| | Mice | 39 | 2026 | 18048 | 0.470 |
Why?
| | Mice, Inbred C57BL | 25 | 2025 | 5887 | 0.470 |
Why?
| | T-Lymphocytes | 8 | 2025 | 2002 | 0.470 |
Why?
| | Th1 Cells | 2 | 2007 | 139 | 0.440 |
Why?
| | Lymphocyte Activation | 8 | 2022 | 1150 | 0.430 |
Why?
| | Antigen Presentation | 3 | 2018 | 220 | 0.390 |
Why?
| | Animals | 44 | 2026 | 37657 | 0.380 |
Why?
| | Thymus Gland | 7 | 2024 | 319 | 0.370 |
Why?
| | Colitis | 3 | 2025 | 266 | 0.350 |
Why?
| | CD4-Positive T-Lymphocytes | 7 | 2026 | 1110 | 0.350 |
Why?
| | Immune Tolerance | 2 | 2025 | 368 | 0.330 |
Why?
| | Mice, Knockout | 13 | 2025 | 3068 | 0.320 |
Why?
| | Major Histocompatibility Complex | 2 | 2024 | 234 | 0.320 |
Why?
| | T-Box Domain Proteins | 3 | 2007 | 100 | 0.320 |
Why?
| | Models, Immunological | 2 | 2007 | 101 | 0.320 |
Why?
| | Histocompatibility Antigens Class II | 3 | 2016 | 369 | 0.320 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 4 | 2012 | 21 | 0.310 |
Why?
| | Interferon-gamma | 4 | 2015 | 792 | 0.290 |
Why?
| | Antigens | 5 | 2020 | 362 | 0.290 |
Why?
| | Lymphocyte Subsets | 2 | 2005 | 88 | 0.280 |
Why?
| | Mutation | 4 | 2020 | 4013 | 0.270 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 2 | 2022 | 101 | 0.250 |
Why?
| | Inflammation | 5 | 2025 | 2890 | 0.240 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2025 | 26 | 0.230 |
Why?
| | Colon | 2 | 2025 | 300 | 0.230 |
Why?
| | C-Peptide | 1 | 2026 | 167 | 0.220 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 38 | 0.220 |
Why?
| | HLA-DRB1 Chains | 1 | 2025 | 112 | 0.210 |
Why?
| | Th17 Cells | 1 | 2025 | 107 | 0.210 |
Why?
| | Autoantigens | 2 | 2011 | 422 | 0.210 |
Why?
| | Genes, T-Cell Receptor alpha | 1 | 2003 | 12 | 0.210 |
Why?
| | Catecholamines | 1 | 2023 | 93 | 0.200 |
Why?
| | NADPH Oxidases | 1 | 2024 | 140 | 0.200 |
Why?
| | Phagocytes | 1 | 2024 | 103 | 0.200 |
Why?
| | Methionine | 1 | 2024 | 159 | 0.200 |
Why?
| | Transcription Factors | 3 | 2005 | 1703 | 0.200 |
Why?
| | Glutamic Acid | 1 | 2025 | 256 | 0.190 |
Why?
| | Antigens, Differentiation, B-Lymphocyte | 1 | 2002 | 37 | 0.190 |
Why?
| | Interleukin-4 | 1 | 2003 | 215 | 0.190 |
Why?
| | Lung Injury | 1 | 2025 | 227 | 0.190 |
Why?
| | Collagen | 1 | 2025 | 459 | 0.190 |
Why?
| | Th2 Cells | 1 | 2003 | 177 | 0.190 |
Why?
| | Interleukin-15 | 1 | 2002 | 101 | 0.180 |
Why?
| | Dendritic Cells | 3 | 2020 | 505 | 0.180 |
Why?
| | Histone Deacetylases | 1 | 2023 | 209 | 0.180 |
Why?
| | Acute Lung Injury | 1 | 2025 | 304 | 0.180 |
Why?
| | Genes, T-Cell Receptor beta | 1 | 2001 | 23 | 0.180 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2023 | 210 | 0.180 |
Why?
| | Adipocytes | 1 | 2023 | 227 | 0.180 |
Why?
| | Lipopolysaccharides | 1 | 2025 | 889 | 0.180 |
Why?
| | Casein Kinase II | 1 | 2020 | 21 | 0.170 |
Why?
| | Dermis | 1 | 2020 | 34 | 0.170 |
Why?
| | Listeriosis | 1 | 2020 | 69 | 0.160 |
Why?
| | Signal Transduction | 4 | 2020 | 5144 | 0.160 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2020 | 23 | 0.160 |
Why?
| | Immunity | 1 | 2020 | 140 | 0.160 |
Why?
| | Intestinal Mucosa | 1 | 2025 | 631 | 0.160 |
Why?
| | Gene Expression Regulation | 3 | 2013 | 2599 | 0.160 |
Why?
| | Listeria monocytogenes | 1 | 2020 | 121 | 0.160 |
Why?
| | Myeloid Cells | 1 | 2020 | 151 | 0.150 |
Why?
| | Respiratory Hypersensitivity | 2 | 2010 | 68 | 0.140 |
Why?
| | B7-H1 Antigen | 1 | 2020 | 221 | 0.140 |
Why?
| | Immunologic Memory | 1 | 2020 | 360 | 0.140 |
Why?
| | Mice, Transgenic | 6 | 2025 | 2180 | 0.140 |
Why?
| | Mice, Inbred BALB C | 4 | 2018 | 1274 | 0.140 |
Why?
| | Glycolipids | 1 | 2018 | 44 | 0.130 |
Why?
| | Autoimmunity | 2 | 2020 | 908 | 0.130 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 497 | 0.130 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2026 | 3776 | 0.130 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2016 | 37 | 0.130 |
Why?
| | B-Lymphocytes | 1 | 2022 | 858 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 506 | 0.120 |
Why?
| | Lung | 5 | 2025 | 4134 | 0.120 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2016 | 40 | 0.120 |
Why?
| | Apoptosis | 1 | 2025 | 2574 | 0.120 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2016 | 393 | 0.120 |
Why?
| | Lipids | 1 | 2001 | 689 | 0.120 |
Why?
| | Arthritis, Rheumatoid | 1 | 2025 | 1176 | 0.120 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 875 | 0.110 |
Why?
| | Epithelial Cells | 3 | 2020 | 1110 | 0.110 |
Why?
| | Fibroblasts | 1 | 2020 | 1020 | 0.110 |
Why?
| | Insulin | 1 | 2026 | 2482 | 0.110 |
Why?
| | Pseudomonas Infections | 1 | 2016 | 230 | 0.110 |
Why?
| | Disease Models, Animal | 5 | 2025 | 4404 | 0.110 |
Why?
| | Cellular Senescence | 1 | 2016 | 205 | 0.110 |
Why?
| | Pseudomonas aeruginosa | 1 | 2016 | 358 | 0.110 |
Why?
| | Cells, Cultured | 7 | 2020 | 4208 | 0.100 |
Why?
| | Interleukins | 1 | 2015 | 248 | 0.100 |
Why?
| | Cytokines | 3 | 2025 | 2098 | 0.100 |
Why?
| | Ovalbumin | 2 | 2010 | 196 | 0.100 |
Why?
| | Mice, Inbred NOD | 2 | 2026 | 600 | 0.090 |
Why?
| | Tuberculosis | 1 | 2015 | 285 | 0.090 |
Why?
| | Mycobacterium tuberculosis | 1 | 2015 | 320 | 0.090 |
Why?
| | Alleles | 2 | 2025 | 891 | 0.090 |
Why?
| | Retroviridae | 2 | 2013 | 103 | 0.080 |
Why?
| | Neutrophils | 1 | 2016 | 1282 | 0.080 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2024 | 720 | 0.080 |
Why?
| | Phosphorylation | 3 | 2020 | 1768 | 0.080 |
Why?
| | Lung Diseases | 1 | 2016 | 794 | 0.080 |
Why?
| | Lymph Nodes | 3 | 2020 | 502 | 0.080 |
Why?
| | Macrophages | 1 | 2016 | 1561 | 0.070 |
Why?
| | Smoking | 1 | 2016 | 1601 | 0.070 |
Why?
| | NK Cell Lectin-Like Receptor Subfamily B | 2 | 2015 | 9 | 0.070 |
Why?
| | Antigens, Ly | 2 | 2015 | 43 | 0.070 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2008 | 226 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2020 | 918 | 0.070 |
Why?
| | Receptors, CXCR3 | 1 | 2007 | 12 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2007 | 49 | 0.070 |
Why?
| | Estrogen Antagonists | 1 | 2007 | 45 | 0.070 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2007 | 28 | 0.070 |
Why?
| | Allergens | 1 | 2010 | 401 | 0.060 |
Why?
| | Complementarity Determining Regions | 2 | 2007 | 51 | 0.060 |
Why?
| | Tamoxifen | 1 | 2007 | 203 | 0.060 |
Why?
| | Cathepsin D | 1 | 2026 | 20 | 0.060 |
Why?
| | Humans | 13 | 2026 | 141187 | 0.060 |
Why?
| | Molecular Sequence Data | 2 | 2001 | 2929 | 0.060 |
Why?
| | Sphingomyelins | 1 | 2025 | 22 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2009 | 698 | 0.060 |
Why?
| | Sphingolipids | 1 | 2025 | 80 | 0.060 |
Why?
| | Ceramides | 1 | 2025 | 118 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 987 | 0.050 |
Why?
| | Skin Transplantation | 1 | 2025 | 85 | 0.050 |
Why?
| | Amino Acid Sequence | 2 | 2016 | 2158 | 0.050 |
Why?
| | Receptors, Estrogen | 1 | 2007 | 412 | 0.050 |
Why?
| | Anaerobiosis | 1 | 2024 | 65 | 0.050 |
Why?
| | Uncoupling Protein 1 | 1 | 2023 | 17 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2025 | 310 | 0.050 |
Why?
| | Receptors, Interleukin-12 | 1 | 2003 | 7 | 0.050 |
Why?
| | Bone Marrow Transplantation | 1 | 2025 | 294 | 0.050 |
Why?
| | Thermogenesis | 1 | 2023 | 44 | 0.050 |
Why?
| | Receptors, Interleukin | 1 | 2003 | 45 | 0.050 |
Why?
| | Heterozygote | 1 | 2024 | 307 | 0.050 |
Why?
| | Crosses, Genetic | 1 | 2003 | 133 | 0.050 |
Why?
| | Adipose Tissue, Brown | 1 | 2023 | 56 | 0.050 |
Why?
| | Crystallography, X-Ray | 2 | 2018 | 485 | 0.050 |
Why?
| | Immunity, Innate | 3 | 2016 | 852 | 0.050 |
Why?
| | Receptors, Interferon | 1 | 2023 | 52 | 0.050 |
Why?
| | Respiration | 1 | 2024 | 210 | 0.050 |
Why?
| | CD40 Antigens | 1 | 2003 | 89 | 0.050 |
Why?
| | Immunophenotyping | 2 | 2001 | 329 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1056 | 0.050 |
Why?
| | Lymphopenia | 1 | 2002 | 67 | 0.050 |
Why?
| | Cell Survival | 1 | 2005 | 1129 | 0.050 |
Why?
| | Interleukin-7 | 1 | 2002 | 62 | 0.050 |
Why?
| | Salmonella typhimurium | 1 | 2024 | 185 | 0.050 |
Why?
| | Clonal Anergy | 1 | 2022 | 52 | 0.050 |
Why?
| | Homeostasis | 2 | 2004 | 636 | 0.050 |
Why?
| | Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2001 | 27 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2022 | 119 | 0.050 |
Why?
| | Interferons | 1 | 2023 | 195 | 0.050 |
Why?
| | Carbohydrate Sequence | 1 | 2001 | 28 | 0.040 |
Why?
| | Insulin-Secreting Cells | 1 | 2026 | 382 | 0.040 |
Why?
| | Antigens, Protozoan | 1 | 2001 | 28 | 0.040 |
Why?
| | Protein Conformation | 2 | 2018 | 941 | 0.040 |
Why?
| | Antigens, Fungal | 1 | 2001 | 27 | 0.040 |
Why?
| | Chemokine CCL21 | 1 | 2020 | 14 | 0.040 |
Why?
| | Organ Specificity | 1 | 2001 | 312 | 0.040 |
Why?
| | Receptors, CCR7 | 1 | 2020 | 32 | 0.040 |
Why?
| | Cell Division | 1 | 2002 | 798 | 0.040 |
Why?
| | Poly I-C | 1 | 2020 | 63 | 0.040 |
Why?
| | Lectins, C-Type | 1 | 2000 | 63 | 0.040 |
Why?
| | Lymphatic System | 1 | 2020 | 14 | 0.040 |
Why?
| | Female | 5 | 2026 | 75515 | 0.040 |
Why?
| | Intestine, Large | 1 | 2000 | 14 | 0.040 |
Why?
| | Antigens, Surface | 1 | 2000 | 156 | 0.040 |
Why?
| | Antigens, Bacterial | 1 | 2001 | 125 | 0.040 |
Why?
| | Dimerization | 1 | 2000 | 196 | 0.040 |
Why?
| | Chemotaxis | 1 | 2020 | 133 | 0.040 |
Why?
| | GTP-Binding Proteins | 1 | 2020 | 153 | 0.040 |
Why?
| | Polymerization | 1 | 2020 | 128 | 0.040 |
Why?
| | Cell Count | 1 | 2020 | 326 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2002 | 310 | 0.040 |
Why?
| | Leukocyte Common Antigens | 1 | 2000 | 90 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 175 | 0.040 |
Why?
| | CD4 Antigens | 1 | 2000 | 141 | 0.040 |
Why?
| | Clone Cells | 1 | 2000 | 266 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2026 | 804 | 0.040 |
Why?
| | Epitopes | 1 | 2001 | 477 | 0.040 |
Why?
| | Exons | 1 | 2020 | 353 | 0.040 |
Why?
| | Mice, SCID | 1 | 2000 | 367 | 0.040 |
Why?
| | Adipose Tissue | 1 | 2023 | 647 | 0.040 |
Why?
| | Protein Domains | 1 | 2020 | 301 | 0.040 |
Why?
| | Bleomycin | 1 | 2020 | 248 | 0.040 |
Why?
| | DNA Repair | 1 | 2020 | 234 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2005 | 1764 | 0.040 |
Why?
| | Actins | 1 | 2020 | 423 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2003 | 2828 | 0.040 |
Why?
| | Immunoglobulin Variable Region | 2 | 2012 | 81 | 0.030 |
Why?
| | Spleen | 1 | 2000 | 525 | 0.030 |
Why?
| | Cell Cycle | 1 | 2020 | 597 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2001 | 528 | 0.030 |
Why?
| | Bacteriolysis | 1 | 2016 | 9 | 0.030 |
Why?
| | Base Sequence | 1 | 2020 | 2180 | 0.030 |
Why?
| | Amino Acids | 1 | 2020 | 497 | 0.030 |
Why?
| | Smad1 Protein | 1 | 2016 | 17 | 0.030 |
Why?
| | Activin Receptors, Type II | 1 | 2016 | 12 | 0.030 |
Why?
| | Peroxidase | 1 | 2016 | 182 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2018 | 398 | 0.030 |
Why?
| | Germ Cells | 1 | 2016 | 64 | 0.030 |
Why?
| | Bone Marrow Cells | 2 | 2010 | 325 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2013 | 1197 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 330 | 0.030 |
Why?
| | CRISPR-Cas Systems | 1 | 2016 | 150 | 0.030 |
Why?
| | RNA Splice Sites | 1 | 2015 | 50 | 0.030 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2015 | 44 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2022 | 1448 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 3166 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2885 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2020 | 816 | 0.030 |
Why?
| | Proteins | 1 | 2000 | 1010 | 0.030 |
Why?
| | Transgenes | 1 | 2015 | 186 | 0.030 |
Why?
| | Early Growth Response Protein 2 | 1 | 2013 | 10 | 0.030 |
Why?
| | Virulence | 1 | 2015 | 268 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2020 | 1487 | 0.030 |
Why?
| | Thymocytes | 1 | 2013 | 35 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2015 | 173 | 0.030 |
Why?
| | Surface Plasmon Resonance | 1 | 2013 | 88 | 0.030 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2020 | 659 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2020 | 2504 | 0.020 |
Why?
| | Transfection | 1 | 2015 | 943 | 0.020 |
Why?
| | Immune System | 1 | 2013 | 183 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2015 | 396 | 0.020 |
Why?
| | Receptors, Natural Killer Cell | 1 | 2011 | 16 | 0.020 |
Why?
| | Peptides | 1 | 2016 | 978 | 0.020 |
Why?
| | Protein Binding | 1 | 2016 | 2239 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1250 | 0.020 |
Why?
| | Bronchial Hyperreactivity | 1 | 2010 | 104 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2011 | 169 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2010 | 223 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2010 | 245 | 0.020 |
Why?
| | Crystallization | 1 | 2009 | 146 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2013 | 1242 | 0.020 |
Why?
| | Mutagenesis | 1 | 2009 | 182 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2009 | 533 | 0.020 |
Why?
| | Ligands | 1 | 2010 | 667 | 0.020 |
Why?
| | Crystallography | 1 | 2007 | 29 | 0.020 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2007 | 14 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2007 | 12 | 0.020 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2007 | 17 | 0.020 |
Why?
| | Receptors, Retinoic Acid | 1 | 2007 | 41 | 0.020 |
Why?
| | Intubation, Intratracheal | 1 | 2010 | 286 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2010 | 519 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 309 | 0.020 |
Why?
| | Models, Molecular | 1 | 2011 | 1603 | 0.010 |
Why?
| | Precipitin Tests | 1 | 2004 | 98 | 0.010 |
Why?
| | CpG Islands | 1 | 2004 | 163 | 0.010 |
Why?
| | Organ Culture Techniques | 1 | 2003 | 157 | 0.010 |
Why?
| | Time Factors | 1 | 2013 | 6956 | 0.010 |
Why?
| | Stromal Cells | 1 | 2003 | 117 | 0.010 |
Why?
| | Cloning, Organism | 1 | 2002 | 6 | 0.010 |
Why?
| | Immunoglobulin Joining Region | 1 | 2001 | 10 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2004 | 761 | 0.010 |
Why?
| | Liver | 1 | 2010 | 1819 | 0.010 |
Why?
| | Hematopoietic Stem Cells | 1 | 2004 | 411 | 0.010 |
Why?
| | Cell Lineage | 1 | 2001 | 350 | 0.010 |
Why?
| | Stem Cells | 1 | 2001 | 602 | 0.010 |
Why?
| | Aged | 1 | 2016 | 24574 | 0.010 |
Why?
| | Middle Aged | 1 | 2016 | 34434 | 0.010 |
Why?
| | Male | 1 | 2020 | 69783 | 0.010 |
Why?
| | Aging | 1 | 2002 | 1892 | 0.010 |
Why?
|
|
Matsuda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|